Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel SSTR antagonist [177Lu]DOTA-LM3 shows promising results in patients with NENs

July 14, 2020

Discovery of KB-00130742 as orally bioavailable and ultra-selective inhibitor of CDK9

July 14, 2020

KPG-121, a cereblon modulator, shows promising antitumor activity in vitro and in vivo

July 14, 2020

Beta Pharma begins phase I/II study of BPI-1178 in advanced solid tumors and breast cancer

July 13, 2020

BRAF inhibitor ABM-1310 displays potent efficacy in xenograft cancer models

July 13, 2020

First-in-human study of INV-1120

July 13, 2020

Imperial Innovations Group presents N-myristoyltransferase inhibitors

July 13, 2020

New SMARCA2 inhibitors identified at Bayer

July 13, 2020

Discovery of novel BET protein degraders as oncolytic drug candidates

July 13, 2020

Uppsala University researchers describe new urothelial bladder cancer model

July 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...